For more than 20 years, Pfizer has been advancing understanding of the immune system and innovating in rheumatology, gastroenterology, and medical dermatology. As a global healthcare leader, Pfizer focuses its efforts on six major therapeutic areas: vaccines, oncology, rare diseases, inflammation and immunology, internal medicine, and anti-infectives. In France, Pfizer relies on open and collaborative R&D, in partnership with leading institutions such as INSERM, the Pasteur Institute, the Brain Institute, and Unicancer, as well as numerous innovative biotechnology companies. The group is investing more than €1 billion between now and 2026 to strengthen research, development, and drug production in France.
Top santé's mission is to provide accurate, analytical answers to the questions French people ask about their health, by providing rigorous, reliable information that never raises anxiety. Top santé's editorial line revolves around two key words: ENGAGEMENT, with strong bias to guide its [...]
La Poste is a publicly owned corporation and a subsidiary of Caisse des Dépôts and the French government. The La Poste Group is organized into four divisions: Mail, Parcel, and Services; Consumer and Digital; Geopost; and La Banque Postale, which, together with its subsidiary CNP Assurances, ranks [...]
Valbiotis designs and develops high-quality, scientifically tested dietary supplements to support cardiometabolic health and daily well-being. With over 10 years of expertise in research and development, the laboratory adheres to scientific standards inspired by pharmaceutical development to ensure [...]